244 related articles for article (PubMed ID: 15935710)
1. Functional consequences of ferroportin 1 mutations.
Liu XB; Yang F; Haile DJ
Blood Cells Mol Dis; 2005; 35(1):33-46. PubMed ID: 15935710
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
[TBL] [Abstract][Full Text] [Related]
3. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
[TBL] [Abstract][Full Text] [Related]
4. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
5. Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages.
Liu XB; Nguyen NB; Marquess KD; Yang F; Haile DJ
Blood Cells Mol Dis; 2005; 35(1):47-56. PubMed ID: 15932798
[TBL] [Abstract][Full Text] [Related]
6. Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process.
Gagliardo B; Kubat N; Faye A; Jaouen M; Durel B; Deschemin JC; Canonne-Hergaux F; Sari MA; Vaulont S
J Hepatol; 2009 Feb; 50(2):394-401. PubMed ID: 19070914
[TBL] [Abstract][Full Text] [Related]
7. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.
Donovan A; Lima CA; Pinkus JL; Pinkus GS; Zon LI; Robine S; Andrews NC
Cell Metab; 2005 Mar; 1(3):191-200. PubMed ID: 16054062
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin inhibits apical iron uptake in intestinal cells.
Mena NP; Esparza A; Tapia V; Valdés P; Núñez MT
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G192-8. PubMed ID: 17962361
[TBL] [Abstract][Full Text] [Related]
9. [Role of hepcidin in the pathogenesis of hemochromatosis].
Altes Hernández A; Aranalde Fortó J
Gastroenterol Hepatol; 2009 Nov; 32(9):622-6. PubMed ID: 19625109
[TBL] [Abstract][Full Text] [Related]
10. Genetic and clinical heterogeneity of ferroportin disease.
Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload.
Duca L; Delbini P; Nava I; Vaja V; Fiorelli G; Cappellini MD
Am J Hematol; 2009 Sep; 84(9):592-3. PubMed ID: 19610021
[TBL] [Abstract][Full Text] [Related]
12. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of duodenal and macrophage ferroportin proteins.
Canonne-Hergaux F; Donovan A; Delaby C; Wang HJ; Gros P
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G156-63. PubMed ID: 16081760
[TBL] [Abstract][Full Text] [Related]
14. The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes.
Ge XH; Wang Q; Qian ZM; Zhu L; Du F; Yung WH; Yang L; Ke Y
J Nutr Biochem; 2009 Nov; 20(11):860-5. PubMed ID: 19027283
[TBL] [Abstract][Full Text] [Related]
15. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
16. Cellular iron: ferroportin is the only way out.
Ganz T
Cell Metab; 2005 Mar; 1(3):155-7. PubMed ID: 16054057
[TBL] [Abstract][Full Text] [Related]
17. Wild-type and mutant ferroportins do not form oligomers in transfected cells.
Gonçalves AS; Muzeau F; Blaybel R; Hetet G; Driss F; Delaby C; Canonne-Hergaux F; Beaumont C
Biochem J; 2006 Jun; 396(2):265-75. PubMed ID: 16457665
[TBL] [Abstract][Full Text] [Related]
18. Lipid raft-dependent endocytosis: a new route for hepcidin-mediated regulation of ferroportin in macrophages.
Auriac A; Willemetz A; Canonne-Hergaux F
Haematologica; 2010 Aug; 95(8):1269-77. PubMed ID: 20220061
[TBL] [Abstract][Full Text] [Related]
19. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia.
Lasocki S; Millot S; Andrieu V; Lettéron P; Pilard N; Muzeau F; Thibaudeau O; Montravers P; Beaumont C
Crit Care Med; 2008 Aug; 36(8):2388-94. PubMed ID: 18664788
[TBL] [Abstract][Full Text] [Related]
20. Iron regulatory and bactericidal properties of human recombinant hepcidin expressed in Pichia pastoris.
Koliaraki V; Marinou M; Samiotaki M; Panayotou G; Pantopoulos K; Mamalaki A
Biochimie; 2008 May; 90(5):726-35. PubMed ID: 18295606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
